You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

RNA Synthetase Inhibitor Antibacterial Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: RNA Synthetase Inhibitor Antibacterial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Inc MUPIROCIN mupirocin calcium CREAM;TOPICAL 201587-001 Jan 24, 2013 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva MUPIROCIN mupirocin OINTMENT;TOPICAL 065085-001 Nov 7, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal MUPIROCIN mupirocin calcium CREAM;TOPICAL 214811-001 Nov 15, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro MUPIROCIN mupirocin OINTMENT;TOPICAL 065170-001 Sep 23, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.